Lactate-driven H3K18 lactylation promotes cisplatin resistance in bladder cancer via HNRNPF-Parkin mediated mitophagy
Drug Resistance Updates · 2026-09 · 88 · 101435
DOI: 10.1016/j.drup.2026.101435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2026-09. Verfasst von Henghui Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, PR China. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Urinary Bladder Neoplasms, Cisplatin. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Guangdong Provincial Natural Science Foundation, Southern Medical University Nanfang Hospital, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, PR China.
- Department of Urology, Zigong Fourth People's Hospital, Zigong, Sichuan 643000, PR China.
- School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, 999077, Hong Kong Special Administrative Region of China.
- Macao Centre for Research and Development in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, 999078, Macao Special Administrative Region of China.
- School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China.
- Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, PR China.
Förderung
- Guangdong Provincial Natural Science Foundation
- Southern Medical University Nanfang Hospital
- National Natural Science Foundation of China
- Southern Medical University
Zitieren
APA
Zhang, H., Li, D., Su, M., Zheng, Z., Chen, W., Chen, H., Zhong, Z., Fan, Q., Deng, F., Hou, L., Zhao, G., Tan, W., & Li, F. (2026). Lactate-driven H3K18 lactylation promotes cisplatin resistance in bladder cancer via HNRNPF-Parkin mediated mitophagy. Drug Resistance Updates, 88, 101435. https://doi.org/10.1016/j.drup.2026.101435
Vancouver
Zhang H, Li D, Su M, Zheng Z, Chen W, Chen H, et al. Lactate-driven H3K18 lactylation promotes cisplatin resistance in bladder cancer via HNRNPF-Parkin mediated mitophagy. Drug Resistance Updates. 2026;88:101435. doi:10.1016/j.drup.2026.101435
BibTeX
@article{Zhang2026,
author = {Zhang, Henghui and Li, Dongqing and Su, Mingqiang and Zheng, Zaosong and Chen, Wei and Chen, Haiyong and Zhong, Zhangfeng and Fan, Qin and Deng, Fan and Hou, Lina and Zhao, Guozhi and Tan, Wanlong and Li, Fei},
title = {Lactate-driven H3K18 lactylation promotes cisplatin resistance in bladder cancer via HNRNPF-Parkin mediated mitophagy},
journal = {Drug Resistance Updates},
year = {2026},
volume = {88},
pages = {101435},
doi = {10.1016/j.drup.2026.101435}
}
EUVIMED